Equities analysts forecast that NutriSystem Inc. (NASDAQ:NTRI) will announce sales of $129.22 million for the current fiscal quarter, according to Zacks Investment Research. Three analysts have issued estimates for NutriSystem’s earnings, with the highest sales estimate coming in at $131.10 million and the lowest estimate coming in at $128.00 million. NutriSystem reported sales of $108.95 million during the same quarter last year, which indicates a positive year-over-year growth rate of 18.6%. The firm is scheduled to announce its next quarterly earnings report after the market closes on Monday, February 26th.

According to Zacks, analysts expect that NutriSystem will report full-year sales of $129.22 million for the current fiscal year, with estimates ranging from $693.70 million to $696.80 million. For the next financial year, analysts expect that the company will post sales of $797.72 million per share, with estimates ranging from $794.70 million to $803.50 million. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side analysts that follow NutriSystem.

A number of equities analysts have commented on NTRI shares. B. Riley set a $74.00 price target on NutriSystem and gave the stock a “buy” rating in a research note on Thursday, October 26th. Lake Street Capital set a $73.00 price target on NutriSystem and gave the stock a “buy” rating in a research note on Thursday, October 26th. Zacks Investment Research raised NutriSystem from a “hold” rating to a “buy” rating and set a $58.00 price target on the stock in a research note on Saturday, October 28th. DA Davidson reaffirmed a “buy” rating and issued a $80.00 price target on shares of NutriSystem in a research note on Friday, December 22nd. Finally, BidaskClub cut NutriSystem from a “hold” rating to a “sell” rating in a research note on Tuesday, January 23rd. Three research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $67.56.

In other news, CEO Dawn M. Zier sold 30,006 shares of the business’s stock in a transaction that occurred on Friday, January 12th. The stock was sold at an average price of $52.36, for a total transaction of $1,571,114.16. Following the transaction, the chief executive officer now directly owns 224,659 shares of the company’s stock, valued at $11,763,145.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Dawn M. Zier sold 11,000 shares of the business’s stock in a transaction that occurred on Thursday, December 14th. The shares were sold at an average price of $49.94, for a total value of $549,340.00. Following the transaction, the insider now directly owns 210,666 shares in the company, valued at $10,520,660.04. The disclosure for this sale can be found here. Insiders have sold 96,831 shares of company stock worth $4,627,659 over the last three months. Insiders own 2.40% of the company’s stock.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in NTRI. Cypress Capital Management LLC WY bought a new stake in shares of NutriSystem during the third quarter valued at approximately $112,000. Ameritas Investment Partners Inc. boosted its position in shares of NutriSystem by 10.9% during the second quarter. Ameritas Investment Partners Inc. now owns 2,608 shares of the company’s stock valued at $136,000 after purchasing an additional 257 shares in the last quarter. Koch Industries Inc. bought a new stake in shares of NutriSystem during the second quarter valued at approximately $233,000. Polen Capital Management LLC bought a new stake in shares of NutriSystem during the fourth quarter valued at approximately $249,000. Finally, BlueCrest Capital Management Ltd bought a new stake in shares of NutriSystem during the second quarter valued at approximately $262,000.

NutriSystem (NTRI) opened at $42.15 on Thursday. The company has a market capitalization of $1,248.14, a P/E ratio of 22.70, a price-to-earnings-growth ratio of 0.99 and a beta of 0.72. NutriSystem has a 12 month low of $34.40 and a 12 month high of $67.95.

NutriSystem declared that its board has initiated a stock buyback plan on Wednesday, October 25th that allows the company to buyback $50.00 million in outstanding shares. This buyback authorization allows the company to repurchase shares of its stock through open market purchases. Shares buyback plans are usually a sign that the company’s board believes its shares are undervalued.

ILLEGAL ACTIVITY WARNING: This article was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another domain, it was stolen and reposted in violation of US and international copyright & trademark law. The legal version of this article can be read at https://www.thecerbatgem.com/2018/02/15/zacks-analysts-anticipate-nutrisystem-inc-ntri-will-announce-quarterly-sales-of-129-22-million.html.

About NutriSystem

Nutrisystem, Inc is a provider of weight management products and services, including nutritionally balanced weight loss programs, multi-day kits available at retail locations and digital tools to support weight loss. The Company’s program customers purchase monthly food packages containing four-week meal plan consisting supply of breakfasts, lunches, dinners and snacks and flex meal plan recipes, which they supplement with fresh fruits, vegetables and dairy.

Get a free copy of the Zacks research report on NutriSystem (NTRI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for NutriSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NutriSystem and related companies with MarketBeat.com's FREE daily email newsletter.